Pathogenic factors and prognosis of non-cardiac inpatients with acute myocardial infarction

National Medical Journal of China

Volumn 93, Issue 19, 2013, Pages 1463-1468

  Cao, Ming Ying ^a   Yao, Zhu Hua ^a   Zhou, Xin ^a   Zheng, Quan Xiu ^a   Cai, Hong Bin ^a  

^a TIANJIN UNION MEDICAL CENTER   (China)

Author keywords

Factor analysis; Myocardial infarction; Prognosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; AGE; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONSULTATION; DEHYDRATION; DISEASE SEVERITY; EMERGENCY SURGERY; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PATHOGENESIS; PROGNOSIS; TREATMENT WITHDRAWAL;

AGED; FEMALE; HUMANS; INPATIENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84879134816     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.19.007     Document Type: Article

References (12)

1. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006, 295:1681-1687.
2. Nakbi A, Koubaa N, Ben Hamda K, et al. Association between oxidative stress parameters and inflammation markers according to the gravity of the acute coronary syndrome. Tunis Med, 2011, 89:621-626.
3. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2008, 117:1610-1619.
4. Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: Potential association with C-reactive protein. Circ J, 2008, 72:415-419.
5. Wong V W, McLean M, Boyages S C, et al. C-reactive protein levels following acute myocardial infarction: Effect of insulin infusion and tight glycemic control. Diabetes Care, 2004, 27:2971-2973.
6. Newsome L T, Weller R S, Gerancher J C, et al. Coronary artery stents: II. Perioperative considerations and management. Anesth Analg, 2008, 107:570-590.
7. Chassot P G, Delabays A, Spahn D R. Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth, 2007, 99:316-328.
8. Llau J V, Lopez-Forte C, Sapena L, et al. Perioperative management of antiplatelet agents in noncardiac surgery. Eur J Anaesthesiol, 2009, 26:181-187.
9. Rittger H, Hochadel M, Behrens S, et al. Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: Results from the German ALKK registry. Eurolntervention, 2012, 7:1197-1205.
10. 2009, 8:235-239.
11. Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci, 2007, 1100:353-360.
12. Sielski J, Janion-Sadowska A, Sadowski M, et al. Differences in presentation, treatment, and prognosis in elderly patients with non-ST-segment elevation myocardial infarction. Pol Arch Med Wewn, 2012, 122:253-261.